dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Grau Vorster, Marta |
dc.contributor.author | Lopez Montañes, Maria |
dc.contributor.author | Canto Puig, Ester |
dc.contributor.author | Vives Armengol, Joaquim |
dc.contributor.author | Oliver-Vila, Irene |
dc.contributor.author | Barba Suñol, Pere |
dc.contributor.author | Rudilla Salvador, Francesc |
dc.date.accessioned | 2021-09-08T07:38:53Z |
dc.date.available | 2021-09-08T07:38:53Z |
dc.date.issued | 2020-02-25 |
dc.identifier.citation | Grau-Vorster M, López-Montañés M, Cantó E, Vives J, Oliver-Vila I, Barba P, et al. Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy. Front Immunol. 2020 Feb 25;11:271. |
dc.identifier.issn | 1664-3224 |
dc.identifier.uri | https://hdl.handle.net/11351/6278 |
dc.description | Inmunoterapia adoptiva; Citotoxicidad; Linfocitos T específicos de virus (VST) |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Immunology;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Infeccions per citomegalovirus |
dc.subject | Cèl·lules T |
dc.subject | Immunoteràpia |
dc.subject.mesh | Immunotherapy, Adoptive |
dc.subject.mesh | T-Lymphocytes, Cytotoxic |
dc.subject.mesh | Cytomegalovirus Infections |
dc.title | Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fimmu.2020.00271 |
dc.subject.decs | infecciones por Citomegalovirus |
dc.subject.decs | inmunoterapia adoptiva |
dc.subject.decs | linfocitos T citotóxicos |
dc.relation.publishversion | https://doi.org/10.3389/fimmu.2020.00271 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Grau-Vorster M, López-Montañés M, Cantó E, Rudilla F] Cell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain. Grup de Medicina Transfusional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Vives J] Cell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain. Grup de Medicina Transfusional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Grup d’Enginyeria tissular musculoesquelètica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Oliver-Vila I] Cell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain. [Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 32161589 |
dc.identifier.wos | 000524779300001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0011%2F0028 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR719 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |